These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparative phenotype mapping of normal vs. malignant pediatric B-lymphopoiesis unveils leukemia-associated aberrations. Dworzak MN; Fritsch G; Fleischer C; Printz D; Fröschl G; Buchinger P; Mann G; Gadner H Exp Hematol; 1998 Apr; 26(4):305-13. PubMed ID: 9546313 [TBL] [Abstract][Full Text] [Related]
6. Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement. Bueno C; Montes R; Catalina P; Rodríguez R; Menendez P Leukemia; 2011 Mar; 25(3):400-10. PubMed ID: 21135858 [TBL] [Abstract][Full Text] [Related]
7. Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide. Tulley JM; Palmer JL; Gamelli RL; Faunce DE Shock; 2008 Feb; 29(2):269-77. PubMed ID: 17693934 [TBL] [Abstract][Full Text] [Related]
8. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry. Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032 [TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP). Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914 [TBL] [Abstract][Full Text] [Related]
10. Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. Singh N; Hong S; Scherer DC; Serizawa I; Burdin N; Kronenberg M; Koezuka Y; Van Kaer L J Immunol; 1999 Sep; 163(5):2373-7. PubMed ID: 10452969 [TBL] [Abstract][Full Text] [Related]
11. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia. van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722 [TBL] [Abstract][Full Text] [Related]
12. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181). Estrov Z; Talpaz M; Zipf TF; Kantarjian HM; Ku S; Ouspenskaia MV; Hirsch-Ginsberg C; Huh Y; Yee G; Kurzrock R J Cell Physiol; 1996 Mar; 166(3):618-30. PubMed ID: 8600166 [TBL] [Abstract][Full Text] [Related]
13. Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes. Burdin N; Brossay L; Koezuka Y; Smiley ST; Grusby MJ; Gui M; Taniguchi M; Hayakawa K; Kronenberg M J Immunol; 1998 Oct; 161(7):3271-81. PubMed ID: 9759842 [TBL] [Abstract][Full Text] [Related]
14. T cell receptor gene rearrangements in B-precursor acute lymphoblastic leukemia correlate with age and the stage of B cell differentiation. Nuss R; Kitchingman G; Cross A; Zipf TF; Antoun GR; Bernstein I; Behm F; Pullen DJ; Crist W; Mirro J Leukemia; 1988 Nov; 2(11):722-7. PubMed ID: 2972889 [TBL] [Abstract][Full Text] [Related]
15. Role of γδ T cells in α-galactosylceramide-mediated immunity. Paget C; Chow MT; Duret H; Mattarollo SR; Smyth MJ J Immunol; 2012 Apr; 188(8):3928-39. PubMed ID: 22412194 [TBL] [Abstract][Full Text] [Related]
16. CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia. Thomas X; Archimbaud E; Charrin C; Magaud JP; Fiere D Leukemia; 1995 Feb; 9(2):249-53. PubMed ID: 7532767 [TBL] [Abstract][Full Text] [Related]
17. Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia. Veltroni M; De Zen L; Sanzari MC; Maglia O; Dworzak MN; Ratei R; Biondi A; Basso G; Gaipa G; Haematologica; 2003 Nov; 88(11):1245-52. PubMed ID: 14607753 [TBL] [Abstract][Full Text] [Related]
18. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring. Boublikova L; Kalinova M; Ryan J; Quinn F; O'Marcaigh A; Smith O; Browne P; Stary J; McCann SR; Trka J; Lawler M Leukemia; 2006 Feb; 20(2):254-63. PubMed ID: 16341043 [TBL] [Abstract][Full Text] [Related]
19. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Sriram V; Du W; Gervay-Hague J; Brutkiewicz RR Eur J Immunol; 2005 Jun; 35(6):1692-701. PubMed ID: 15915536 [TBL] [Abstract][Full Text] [Related]
20. CD1d-restricted NKT cell activation enhanced homeostatic proliferation of CD8+ T cells in a manner dependent on IL-4. Ueda N; Kuki H; Kamimura D; Sawa S; Seino K; Tashiro T; Fushuku K; Taniguchi M; Hirano T; Murakami M Int Immunol; 2006 Sep; 18(9):1397-404. PubMed ID: 16914507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]